SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-139582
Filing Date
2016-12-15
Accepted
2016-12-15 08:30:24
Documents
5
Period of Report
2016-12-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v454989_8k.htm 8-K 19134
2 EXHIBIT 3.1 v454989_ex3-1.htm EX-3.1 6711
3 EXHIBIT 3.2 v454989_ex3-2.htm EX-3.2 141048
4 EXHIBIT 99.1 v454989_ex99-1.htm EX-99.1 8506
5 GRAPHIC image_001.jpg GRAPHIC 3104
  Complete submission text file 0001144204-16-139582.txt   181211
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Filer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35112 | Film No.: 162052385
SIC: 2836 Biological Products, (No Diagnostic Substances)